Zoetis Inc. (ZTS) During the most recent session, the shares traded at 0.23 points or 0.42% higher at $55.17. The money flow data is unimpressive with the net money flow value of $(-4.46) million. As per the intraday data, the upticks measured $16.23 million and the downticks measured $20.69 million. As a result, the up/down ratio registered a value of 0.78. The shares have seen 0.95% price change for the week.A block trade also made an entry with $1.49 million flowing in through upticks while $6.17 million flew out through downticks. The block tradeoff had the up/down ratio of 0.24. The net money flow for this big transaction was $(-4.68) million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of Zoetis Inc. rose by 2.44% in the last five trading days and 3.55% for the last 4 weeks. Zoetis Inc. is up 16.19% in the last 3-month period. Year-to-Date the stock performance stands at 3.55%. Zoetis Inc. (NYSE:ZTS) rose 0.69% or 0.38 points on Wednesday and made its way into the gainers of the day. After trading began at $54.93 the stock was seen hitting $55.35 as a peak level and $54.62 as the lowest level. The stock ended up at $55.32. The daily volume was measured at 2,492,158 shares. The 52-week high of the share price is $55.35 and the 52-week low is $38.26. The company has a market cap of $27,319 million.
Company has reported several Insider transactions to the SEC, on Nov 23, 2016, Kristin C Peck (Executive Vice President) sold 10,092 shares at 49.55 per share price.On Nov 9, 2016, Roxanne Lagano (Executive Vice President) sold 9,797 shares at 50.43 per share price.On Sep 6, 2016, Michael B Mccallister (director) purchased 2,000 shares at 51.34 per share price.
Zoetis Inc Last issued its quarterly earnings results on Nov 2, 2016. The company reported $0.52 EPS for the quarter, beating the analyst consensus estimate by $ 0.06. Analyst had a consensus of $0.46. The company had revenue of $1241.00 million for the quarter, compared to analysts expectations of $1224.15 million. The companys revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Zoetis Inc was Initiated by Deutsche Bank on Dec 20, 2016 to Buy, Price Target of the shares are set at $62.Zoetis Inc was Resumed by Piper Jaffray to Overweight on Dec 15, 2016.
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.